What is BiorLabs (BYB) crypto coin? Price, supply, and real-world status in 2025
BYB Price Verification Tool
Compare BYB Prices Across Exchanges
Enter prices from different exchanges to see discrepancies that may indicate market manipulation.
Results
Enter prices to see comparison results.
There are over 25,000 cryptocurrencies out there. Most of them vanish without a trace. BiorLabs (BYB) is one of them - but it’s still hanging on, barely. If you’ve seen it pop up on a trading app and wondered if it’s worth your time, here’s the truth: BiorLabs isn’t a project. It’s a gamble with almost no foundation.
What exactly is BiorLabs (BYB)?
BiorLabs, formerly called BiorBank, rebranded in April 2025. That’s the only real update it’s had in months. The token, BYB, runs on a blockchain with contract address 0xfbcb...1b6141. It was launched with a total supply of 1 billion tokens. As of October 2025, around 986 million are already in circulation. That means nearly all the tokens were released right away - no big future unlocks, no planned releases. Just a lot of supply, and not much demand.
The project claims to be “a bridge between the old and the new,” offering Web3 features in a user-friendly platform. But if that’s true, there’s zero proof. No dApps. No payment integrations. No partnerships. No developer activity. No GitHub repo. No whitepaper. Just a name change and a token on a few exchanges.
Price and market data - a mess
If you check CoinMarketCap, Bybit, Binance, or Bitget, you’ll see wildly different prices for BYB. On CoinMarketCap, it’s around $0.00045. On Bybit, it’s $0.00078. On CoinGecko (from March data), it was $0.00117. That’s a 150% difference between platforms. Why? Because there’s almost no real trading happening.
One exchange reports $0 in 24-hour volume. Another shows $55,000. That’s not market activity - that’s pump-and-dump behavior. A few people are moving the price around, and the rest of the market ignores it. The all-time high was $0.001847 in March 2025. Today, it’s trading at roughly a quarter of that. That’s an 80% drop in just seven months.
Market cap? Around $450,000 on most platforms. That’s less than the cost of a small house in some parts of the U.S. For comparison, Bitcoin’s market cap is over $1 trillion. BiorLabs is 2.2 million times smaller. It’s ranked between #4,700 and #5,500 out of 25,000+ cryptocurrencies. You’re not investing in a coin - you’re betting on a needle in a haystack.
Who owns it? And why does it matter?
CoinMarketCap says there are only 622 verified holders. That’s not a community. That’s a group of speculators who bought in early and are now waiting to bail out. No Reddit threads. No Twitter buzz. No Telegram groups with more than 200 members. No interviews with founders. No press releases beyond the April 2025 rebrand announcement.
When a crypto project has fewer than a thousand holders, it’s not a network. It’s a private club of traders. There’s no real utility, no user base, no reason for the price to go up except someone else buying in at a higher price. That’s the definition of a pump-and-dump scheme.
Can you buy it? Yes - but should you?
You can buy BYB on Bybit, Binance, Bitget, and LBank. The process is simple: sign up, do KYC, deposit funds, search for BYB, and click buy. No special tools. No wallets needed beyond your exchange account. But here’s the catch - once you buy it, where do you go?
You can’t spend it. You can’t stake it. You can’t use it in any app. You can’t even find a single real-world use case. The only value it has is the hope that someone else will pay more for it tomorrow. That’s not investing. That’s gambling with zero edge.
Technical analysis? Conflicting signals
Bitget’s chart shows a “Sell” signal on both 4-hour and daily timeframes. Other platforms don’t even bother giving technical ratings. Why? Because the price moves randomly. One day it jumps 13% on low volume. The next day it drops 5% with no news. That’s not volatility from market demand - it’s manipulation from a few wallets.
The fact that CoinMarketCap reports $0 volume while Bitget reports $55,000 means the data is unreliable. One platform is showing real trades. The other is showing nothing. That’s not a market - it’s a ghost town with a few people throwing rocks.
Why did BiorLabs rebrand? And what happened to BiorBank?
The rebrand from BiorBank to BiorLabs happened on April 25, 2025. That’s the only “news” the project has ever had. No roadmap. No team announcement. No product update. Just a name change. That’s usually a red flag. Projects rebrand when they’re trying to reset expectations after a crash. In this case, the price had already dropped 70% from its peak. Rebranding didn’t fix anything. It just gave the same token a new label.
If this were a real project, there’d be a blog. There’d be GitHub commits. There’d be community AMAs. There’d be something. But there’s nothing. Just a token on exchanges, a few price charts, and silence everywhere else.
Bottom line: Is BiorLabs (BYB) worth anything?
No. Not in any meaningful sense.
It has no utility. No adoption. No development. No community. No transparency. The price is erratic because there’s no real demand. The low market cap and tiny number of holders mean it’s easy to manipulate. The rebrand didn’t fix anything - it just made the same failing project look slightly newer.
If you’re looking to invest in crypto, there are thousands of projects with real teams, working products, and growing user bases. BiorLabs isn’t one of them. It’s a low-cap token with no future. The only people who benefit are the ones who sold early. Everyone else is holding a digital paperweight.
Don’t mistake volatility for opportunity. Don’t mistake a listing on an exchange for legitimacy. And don’t let a name like “BiorLabs” make you think there’s science, innovation, or substance behind it. There isn’t.
Ryan Inouye
November 4, 2025 AT 01:10Cydney Proctor
November 5, 2025 AT 15:53Kevin Mann
November 7, 2025 AT 11:42Kathy Ruff
November 8, 2025 AT 07:20Veeramani maran
November 8, 2025 AT 11:34Robin Hilton
November 10, 2025 AT 06:23Nitesh Bandgar
November 12, 2025 AT 00:00Grace Huegel
November 13, 2025 AT 05:48Chloe Walsh
November 14, 2025 AT 07:53Rob Ashton
November 15, 2025 AT 16:49Stephanie Tolson
November 16, 2025 AT 15:38Arjun Ullas
November 17, 2025 AT 14:28